Recruiting NCT06922370

The Osteoarticular Manifestations in Patients With Gitelman Syndrome

— Observational Gitelman Syndrome CPPD - Calcium Pyrophosphate Deposition Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: conventional radiograph or computed tomography.
Who it may be relevant to: Registry conditions: Gitelman Syndrome, CPPD - Calcium Pyrophosphate Deposition Disease. Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: China
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.

Detailed description

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.

Interventions

Diagnostic test conventional radiograph or computed tomography
patients with gitelman syndrome evaluated with conventional radiograph or computed tomography

Primary outcome measures

The presence of chondrocalcinosis [Time frame: From the enrollment to the performance of the CPPD screen]

Eligibility criteria

Inclusion criteria

Patients confirmed with Gitelman Syndrome

Exclusion criteria

Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model: Cohort

Study locations

China · 1 center

the second affiliated hospital, Zhejiang University School of medicine — Hangzhou

Identifiers

NCT: NCT06922370 · 2021-0670

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗